+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dexamethasone"

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report 2026 - Product Thumbnail Image

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market Report 2026 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market Report 2026 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Tobramycin Eye Drop Market Report 2026 - Product Thumbnail Image

Tobramycin Eye Drop Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Prescription Orthopedic Drugs Market Report 2026 - Product Thumbnail Image

Prescription Orthopedic Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Tenosynovitis Drugs Market Report 2026 - Product Thumbnail Image

Tenosynovitis Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Immunosuppressants Market Report 2026 - Product Thumbnail Image

Immunosuppressants Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Veterinary Autoimmune Disease Therapeutics Market Report 2026 - Product Thumbnail Image

Veterinary Autoimmune Disease Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Monoclonal Antibodies in Veterinary Health Market Report 2026 - Product Thumbnail Image

Monoclonal Antibodies in Veterinary Health Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Systemic Lupus Erythematosus Treatment Market Report 2026 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Relapsing Refractory Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Relapsing Refractory Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
From
Refractory Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Dexamethasone is a corticosteroid drug used to treat a variety of immune disorders, including asthma, allergies, and autoimmune diseases. It is used to reduce inflammation and suppress the immune system. Dexamethasone is available in both oral and injectable forms, and is often prescribed in combination with other drugs. It is also used to treat certain types of cancer, such as leukemia and lymphoma. Dexamethasone is a widely used drug in the treatment of immune disorders, and is available from a variety of pharmaceutical companies. It is often prescribed in combination with other drugs, such as antibiotics, antifungals, and antivirals. It is also used in combination with chemotherapy to treat certain types of cancer. The Dexamethasone market is highly competitive, with many companies offering different formulations and dosages. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies include Mylan, Teva, and Sun Pharmaceuticals. Show Less Read more